Talk:Breast cancer treatment

From Wikipedia, the free encyclopedia

↓    Skip to table of contents    ↓

This is the talk page for discussing improvements to the Breast cancer treatment article.
Please sign and date your posts by typing four tildes (~~~~). Put new text under old text. Click here to start a new topic. New to Wikipedia? Welcome! Ask questions, get answers. This is not a forum for general discussion about the article's subject.	Be polite Assume good faith No personal attacks Be welcoming	Article policies No original research Neutral point of view Verifiability

This article is within the scope of the following WikiProjects:
WikiProject Medicine (Rated B-Class) This article is within the scope of WikiProject Medicine. Please visit the project page for details or ask questions at the doctor's mess. B This page has been rated as B-Class on the quality assessment scale High This article has been rated as High-importance on the importance assessment scale

To-do list for Breast cancer treatment:	edit · history · watch · refresh
Here are some tasks you can do:

[edit] Possibly copyright violation

I just barely split article out from main Breast cancer page. I will scan the article and try to rewrite/paraphrase where possible to avoid copy violation. Consider this a hang on tag for a couple hours until I can do this. Optigan13 05:51, 13 October 2007 (UTC)

You don't have to rewrite it, since the source is Wikipedia. You just have to attribute the parent article for GFDL compliance reasons. I'll do it below and on the article page. -- But|seriously|folks  05:53, 13 October 2007 (UTC)

[edit] Attribution

• The original version of this article incorporated text from the Wikipedia article Breast cancer. -- But|seriously|folks  05:53, 13 October 2007 (UTC)

[edit] LN as indication for XRT

I changed the XRT section from "4 or more LNs" (paraphrasing here) as an indication for post-mastectomy XRT (PMRT) to "substantial involvement" as an indication. The 4 or more recommendation is predominantly based on subset analysis from the randomized Danish PMRT studies. Similar subset analyses demonstrate that the 1-3 positive LN patients have the same relative survival benefit as those with greater numbers of LNs, even with 8 or more nodes removed (median in the study was 7 LN removed, and this has formed the basis for the argument that fewer LNs involved probably do not require PMRT if "adequate" surgery (10 or more nodes) is performed). Three randomized studies have shown a survival benefit for PMRT in node positive patients, while one has not. Thus, the NCCN advocates PMRT for all women with 4 or more nodes involved and "strong consideration" for women with 1-3 nodes involved. I feel the new wording is more permissive in allowing consideration of PMRT in all node positive patients (micromets or IHC excluded, hence the "substantial" wording) rather than just in those women with 4 or more positive nodes. Schwartzenator (talk) 04:47, 20 May 2008 (UTC)